Bin Fu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
Papers in
-
- Circular RNAs in diseases 11
- Epigenetics and DNA Methylation 8
- Surgery 52
- Bladder and Urothelial Cancer Treatments 32
- Adrenal and Paraganglionic Tumors 8
- Co-authors
- Wen Deng (43 shared papers)Xiaoqiang Liu (43 shared papers)Gongxian Wang (25 shared papers)Luyao Chen (41 shared papers)Bin Lang (15 shared papers)Xin Ma (14 shared papers)Ailing Fu (2 shared papers)Hongzhao Li (10 shared papers)
- Journals
- Frontiers in Oncology (19 papers)Journal of Endourology (7 papers)The Journal of Urology (6 papers)Frontiers in Immunology (5 papers)Journal of Oncology (5 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Bin Fu
161 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 128
- Cancer Research 370
- Pulmonary and Respiratory Medicine 385
- Surgery 475
- Urology 57
- Molecular Biology 689
Countries citing papers authored by Bin Fu
This map shows the geographic impact of Bin Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Fu more than expected).
Fields of papers citing papers by Bin Fu
This network shows the impact of papers produced by Bin Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Fu. The network helps show where Bin Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 176 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 115 | |
| 2 | 2020 | 93 | |
| 3 | 2007 | 71 | |
| 4 | 2017 | 61 | |
| 5 | 2011 | 59 | |
| 6 | 2006 | 59 | |
| 7 | 2015 | 51 | |
| 8 | miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT. | 2014 | 50 |
| 9 | 2018 | 42 | |
| 10 | 2007 | 40 | |
| 11 | 2021 | 39 | |
| 12 | 2007 | 38 | |
| 13 | 2023 | 37 | |
| 14 | 2021 | 37 | |
| 15 | 2019 | 36 | |
| 16 | 2019 | 36 | |
| 17 | 2005 | 35 | |
| 18 | 2020 | 33 | |
| 19 | 2021 | 32 | |
| 20 | 2011 | 32 |
About Bin Fu
Bin Fu is a scholar working on Molecular Biology, Surgery, Pulmonary and Respiratory Medicine, Cancer Research and Epidemiology, having authored 176 papers that have together received 2.2k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (32 papers), Renal cell carcinoma treatment (20 papers), Ferroptosis and cancer prognosis (14 papers), Circular RNAs in diseases (11 papers), MicroRNA in disease regulation (9 papers), Epigenetics and DNA Methylation (8 papers), Adrenal and Paraganglionic Tumors (8 papers) and Cancer-related molecular mechanisms research (8 papers). The work is most often cited by research in Cancer Research (370 citations), Pulmonary and Respiratory Medicine (385 citations), Surgery (475 citations), Urology (57 citations) and Molecular Biology (689 citations). Bin Fu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Wen Deng, Xiaoqiang Liu, Gongxian Wang, Luyao Chen, Bin Lang, Xin Ma, Ailing Fu, Hongzhao Li, Kai Xu and Jun Zhang. Their work appears in journals such as Frontiers in Oncology, Journal of Endourology, The Journal of Urology, Frontiers in Immunology and Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.